» Articles » PMID: 32630414

Functional and Mass Spectrometric Evaluation of an Anti-Tick Antigen Based on the P0 Peptide Conjugated to Bm86 Protein

Abstract

A synthetic 20 amino acid peptide of the ribosomal protein P0 from ticks, when conjugated to keyhole limpet hemocyanin from and used as an immunogen against and s.l. species, has shown efficacies of around 90%. There is also experimental evidence of a high efficacy of this conjugate against and species, which suggest that this antigen could be a good broad-spectrum anti-tick vaccine candidate. In this study, the P0 peptide (pP0) was chemically conjugated to Bm86 as a carrier protein. SDS-PAGE analysis of this conjugate demonstrated that it is highly heterogeneous in size, carrying from 1 to 18 molecules of pP0 per molecule of Bm86. Forty-nine out of the 54 lysine residues and the N-terminal end of Bm86 were found partially linked to pP0 by using LC-MS/MS analysis and the combination of four different softwares. Several post-translational modifications of Bm86 protein were also identified by mass spectrometry. High immunogenicity and efficacy were achieved when dogs and cattle were vaccinated with the pP0-Bm86 conjugate and challenged with s.l. and , respectively. These results encourage the development of this antigen with promising possibilities as an anti-tick vaccine.

Citing Articles

Overview of Recombinant Tick Vaccines and Perspectives on the Use of Plant-Made Vaccines to Control Ticks of Veterinary Importance.

Trujillo E, Ramos-Vega A, Monreal-Escalante E, Almazan C, Angulo C Vaccines (Basel). 2024; 12(10).

PMID: 39460344 PMC: 11512348. DOI: 10.3390/vaccines12101178.


Cross-species immunoprotective antigens (subolesin, ferritin 2 and P0) provide protection against Rhipicephalus sanguineus sensu lato.

Zeb I, Parizi L, Israr M, da Silva Vaz Jr I, Ali A Parasit Vectors. 2024; 17(1):3.

PMID: 38172894 PMC: 10765945. DOI: 10.1186/s13071-023-06079-3.


Efficacy of the Vaccine Candidate Based on the P0 Peptide against and Ticks.

Rodriguez-Mallon A, Encinosa Guzman P, Bello Y, Domingos A, Antunes S, Kopacek P Pathogens. 2023; 12(11).

PMID: 38003829 PMC: 10675505. DOI: 10.3390/pathogens12111365.


More than Three Decades of Bm86: What We Know and Where to Go.

Bishop L, Stutzer C, Maritz-Olivier C Pathogens. 2023; 12(9).

PMID: 37764879 PMC: 10537462. DOI: 10.3390/pathogens12091071.


Testing Efficacy of a Conserved Polypeptide from the Bm86 Protein against in the Mexican Tropics.

Coate R, Alonso-Diaz M, Martinez-Velazquez M, Castro-Saines E, Hernandez-Ortiz R, Lagunes-Quintanilla R Vaccines (Basel). 2023; 11(7).

PMID: 37515082 PMC: 10383145. DOI: 10.3390/vaccines11071267.


References
1.
Radulovic Z, Kim T, Porter L, Sze S, Lewis L, Mulenga A . A 24-48 h fed Amblyomma americanum tick saliva immuno-proteome. BMC Genomics. 2014; 15:518. PMC: 4099483. DOI: 10.1186/1471-2164-15-518. View

2.
Fields G, NOBLE R . Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res. 1990; 35(3):161-214. DOI: 10.1111/j.1399-3011.1990.tb00939.x. View

3.
Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M . Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150(1):76-85. DOI: 10.1016/0003-2697(85)90442-7. View

4.
Tabor A, Ali A, Rehman G, Rocha Garcia G, Zangirolamo A, Malardo T . Cattle Tick -Host Interface: A Review of Resistant and Susceptible Host Responses. Front Cell Infect Microbiol. 2018; 7:506. PMC: 5732177. DOI: 10.3389/fcimb.2017.00506. View

5.
Rodriguez-Mallon A, Encinosa P, Mendez-Perez L, Bello Y, Fernandez R, Garay H . High efficacy of a 20 amino acid peptide of the acidic ribosomal protein P0 against the cattle tick, Rhipicephalus microplus. Ticks Tick Borne Dis. 2015; 6(4):530-7. DOI: 10.1016/j.ttbdis.2015.04.007. View